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Cancer invasion is a cell- and tissue-driven process for which the physical, cellular, and molecular
determinants adapt and react throughout the progression of the disease. Cancer invasion is initi-
ated and maintained by signaling pathways that control cytoskeletal dynamics in tumor cells and
the turnover of cell-matrix and cell-cell junctions, followed by cell migration into the adjacent tissue.
Here, we describe the cell-matrix and cell-cell adhesion, protease, and cytokine systems that
underlie tissue invasion by cancer cells. We explain how the reciprocal reprogramming of both
the tumor cells and the surrounding tissue structures not only guides invasion, but also generates
diverse modes of dissemination. The resulting ‘‘plasticity’’ contributes to the generation of diverse
cancer invasion routes and programs, enhanced tumor heterogeneity, and ultimately sustained
metastatic dissemination.Introduction
Cancer invasion and metastasis are landmark events that trans-
form a locally growing tumor into a systemic, metastatic, and
live-threatening disease. The initial steps of local invasion
include the activation of signaling pathways that control
cytoskeletal dynamics in tumor cells and the turnover of cell-
matrix and cell-cell junctions, followed by active tumor cell
migration into the adjacent tissue (Chambers et al., 2002; Friedl
and Wolf, 2003; Sahai, 2007). Metastasis then occurs when
invading tumor cells engage with blood and lymph vessels,
penetrate basement membranes and endothelial walls, and
disseminate through the vessel lumen to colonize distant organs
(Fidler, 2003). Like cells in primary tumors, cells in metastases
also proliferate, invade, and enter blood vessels, leading to
secondary metastasis (Kienast et al., 2010; Armstrong et al.,
2011; Hou et al., 2011).
In the past few decades, cell and tumor biologists have iden-
tified the mechanisms of cell migration in normal and malignant
cells, including the regulation of cell adhesion and cytoskeletal
dynamics (Lauffenburger and Horwitz, 1996; Ridley et al.,
2003; Sanz-Moreno and Marshall, 2010). However, attempts
to define the rate-limiting mechanisms that govern invasive
and metastatic cancer cell migration, such as a dominant
signaling pathway, receptor-ligand interaction, or protease-
substrate interaction, have largely failed. Instead, cancer cell
invasion is now regarded as a heterogeneous and adaptive
process. Indeed, it is this ‘‘plasticity’’ in cell adhesion, cyto-
skeletal dynamics, and mechanotransduction that perpetuates
migration and dissemination under diverse structural, molec-992 Cell 147, November 23, 2011 ª2011 Elsevier Inc.ular, and even adverse microenvironmental conditions (Friedl
and Wolf, 2010; Sahai, 2007; Sanz-Moreno and Marshall,
2010).
Plasticity of invasion, together with other hallmarks of
neoplasia, including cancer cell growth, survival, and genomic
instability, lead to morphological, signaling, and genetic differ-
ences between primary and metastatic lesions within the same
patient (intrapatient heterogeneity), within the same lesion
(intratumoral heterogeneity), and across time (Choi et al., 2011;
Honeth et al., 2008; Lopes et al., 2009; Shapiro et al., 2011;
Stoecklein et al., 2008; Wang et al., 2009).
Such heterogeneous tumor progression is mirrored by an
‘‘activation’’ response of stromal cells nearby the growing tumor,
including fibroblasts, endothelial cells, and macrophages. Once
‘‘activated,’’ these cells reorganize the structure and composi-
tion of the connective tissue by depositing extracellular matrix
components (ECM), cytokines, and growth factors (Egeblad
et al., 2010; He et al., 2011; Picchio et al., 2008; Shapiro et al.,
2011). By remodeling the tissue structure, releasing growth
factors, and imposing metabolic stress, the reactive tumor
stroma, in turn, influences cancer cell functions, often enhancing
tumor growth and invasion and aggravating cancer resistance
during metabolic challenge and therapy (Alexander and Friedl,
2012; Giese et al., 2003; Sansing et al., 2011; Yao et al., 2011).
Thus, in a reciprocal manner, tumor cells influence the stroma
and vice versa, jointly driving cancer progression (Nelson
et al., 2008; Xu et al., 2009). Here, we summarize the adhe-
sion, protease, and cytokine systems that underlie tissue
invasion by cancer cells. We discuss how the reactive tumor
Figure 1. Cell Migration: A Multistep Process
In general, cells can migrate individually or collectively as
multicellular groups.
(A) Single-cell migration involves five molecular steps that
change the cell shape, its position, and the tissue structure
through which it migrates.
(B) Collectively migrating cells form twomajor zones: zone
1, in which a ‘‘leader cell’’ generates a proteolytic micro-
track at the front of the migrating group, and zone 2, in
which the subsequent cells then widen this microtrack to
form a larger macrotrack. (Figure modified from Friedl and
Wolf, 2008.)microenvironment steers plasticity and perpetuates invasion and
metastatic dissemination.
Mechanisms of Cell Migration
Cancer invasion is a cyclic process in which the cell changes
shape, produces morphological asymmetry, and then translo-
cates the cell body. Depending on the cell type and tissue envi-
ronment, cells can migrate in two major ways: individually, when
cell-cell junctions are absent, or collectively as multicellular
groups, when cell-cell adhesions are retained (Friedl and Wolf,
2010) (Figure 1). The underlying process in both types of migra-
tion is the dynamics of the cytoskeleton coupling with cell
surface receptors that engage with surrounding tissue struc-
tures; thus, the cytoskeleton serves as the cell’s engine, and
the cell surface receptors act as its transmission (Ridley et al.,
2003). Cancer cells recapitulate the types and mechanisms of
migration used by normal, nontumor cells. They activate the
same machineries for changing shape, generating force, and
remodeling ECM (Friedl, 2004) as normal cells, but neoplastic
cells lack physiological ‘‘stop signals’’ immobilizing and
anchoring the cells (Cox et al., 2001), which arguably perpetu-
ates neoplastic cell migration.CellInvasive single-cell migration results from five
interdependent molecular steps that change the
cell shape, its position, and the tissue structure
through which it migrates (Friedl and Wolf,
2009; Lauffenburger and Horwitz, 1996; Sheetz
et al., 1999) (Figure 1A). In step 1, the cytoskel-
eton polarizes by actin polymerization and forms
a leading protrusion at the opposite end of
a ‘‘pre-uropod’’ region, which marks the consti-
tutive rear end of the cell (Estecha et al., 2009;
Poincloux et al., 2011). In step 2, the leading
edge protrusion engages with extracellular
substrates, followed by recruitment and adhe-
sion of cell surface receptors that form focalized
clusters and couple extracelluar adhesion to
intracellular mechanosignaling and force gener-
ation (Friedl et al., 1997). In step 3, several
micrometer rearward of the leading edge, cell
surface proteases become engaged with extra-
cellular scaffold proteins and execute locally
controlled proteolysis (Friedl and Wolf, 2009).
This proteolysis modifies the molecular and
mechanical tissue properties and allows spacefor the advancing cell body (Friedl et al., 1997). In step 4, the small
GTPase Rho activates myosin II, and contraction mediated by
actomyosin generates tension inside the cell. In step 5, this
contraction is followedby thegradual turnover of adhesionbonds
at the trailing edge, which slides forward while the leading edge
protrudes further.
In most cells, the leading edge protrusion is controlled by the
small GTPase Rac or Cdc42, which generate pseudopodia or
filopodia that engage with ECM substrate (Sanz-Moreno and
Marshall, 2010). In some cell types with low Rac activity or in
poorly adhesive environments, a variation of steps 1 and 2
occurs (i.e., the pseudopod protrusion and adhesion steps) in
which the leading edge generates leading bleb-like or even
bleb- and pseudopod-free smooth membrane propulsions.
These propulsions are stabilized by cortical F-actin and interca-
late between extracellular tissue structures (Lorentzen et al.,
2011; Poincloux et al., 2011). Here, the force is generated near
the rear pole in an actomyosin- and integrin-dependent manner
(Poincloux et al., 2011).
The physicochemical steps in single-cell migration are coor-
dinatedwithin the same cell body and executed in a synchronous,
often pulsatile manner, which allows the cell body to protrude and147, November 23, 2011 ª2011 Elsevier Inc. 993
Figure 2. Modes of Cell Movement Implicated in
Cancer Invasion and Metastasis
Single-cell and collective cell migration can be further
partitioned based on the specific cell-cell junctions, the
contractility of cytoskeleton, and the turnover of cell
attachments to extracellular matrix (ECM). These modes
of migration can be further unstable and change upon
alterations of cell-cell interactions, cell-ECM adhesion,
or cytoskeletal contractility, resulting in intermediate
phenotypes.generate traction in an oscillatory manner (Ridley et al., 2003).
If multiple cells originate from the same location, such as a
tumor, the ‘‘leader cell’’ forms a proteolytic microtrack of locally
removed ECM barriers (zone 1). The following cells then widen
or excavate this microtrack by mechanical force and proteolysis
to form a larger macrotrack (zone 2) (Ilina et al., 2011; Wolf
et al., 2007) (Figure 1B). In collective migration, protrusion and
retraction are coordinated in a ‘‘supracellular manner,’’ in which
cytoskeletal protrusion and contractility are mechanically
mediated through cell-cell junctions (Hidalgo-Carcedo et al.,
2011; Tambe et al., 2011), allowing the cell group to behave as
‘‘mega-cell’’ (Figure 1B).
Patterns and Diversity of Cancer Cell Invasion
The five-step model of cell migration is active in many types of
cell movement for both normal and neoplastic single cells. Oper-
ationally, individual cell and multicellular migration follow the
paradigm of active cell migration, whereas multicellular growth
leads to passive cell movement by pushing (Figure 2).994 Cell 147, November 23, 2011 ª2011 Elsevier Inc.Rounded/Amoeboid Migration
Cells migrating with low adhesion force or
high actomyosin-mediated contractility adopt
morphologically spherical shapes. This is re-
ferred to here as amoeboid migration because
the Dictyostelium discoideum amoeba mi-
grates by this mechanism (Friedl et al., 2001).
Amoeboid movement, which uses Rac-depen-
dent filopodia, has small or diffusely organized
adhesion sites that generate weak to negligible
adhesion force toward the substrate (La¨mmer-
mann and Sixt, 2009). The second form of
amoeboid movement, which uses Rho-domi-
nated blebbing, lacks defined adhesions and
mediates cell translocation by propulsion using
either blebs or smooth membrane protrusion
at the leading edge and lateral intercalation
(Lorentzen et al., 2011; Paluch et al., 2006;
Poincloux et al., 2011). Amoeboid cells tend
to migrate in the absence of proteolytic
ECM breakdown by adapting their shape to
and squeezing through tissue gaps and
trails (Wolf et al., 2003b). The origin of amoe-
boid tumors is often hematopoietic or neuro-
ectodermal, including leukemias, lymphomas,
and small cell lung carcinoma, but amoeboid
movements are also detected as cell subsetsin most other tumor types (Madsen and Sahai, 2010; Wolf
et al., 2003b).
Mesenchymal Migration
When cytoskeletal protrusions and adhesion capabilities are
strongly developed, invading cells adopt spindle-shaped, elon-
gated morphology with focalized cell-matrix adhesions contain-
ing multimolecular integrin clusters and proteolytic
activity toward ECM substrates (Wolf et al., 2007). Focalized pro-
teases on the cell’s surface generate small microtracks through
which subsequent cells can follow (Friedl and Wolf, 2009) (Fig-
ures 1A and 2). Mesenchymally migrating tumor cells originate
from tumors of the connective tissue, including soft tissue
sarcomas. They also originate from all other tumor types after
the tumor cells dedifferentiate and lose cell-cell junctions (Bra-
bletzet al., 2001;Friedl andWolf, 2009;Sanz-Morenoet al., 2008).
Multicellular Streaming
When individual cells move one after each other using the same
path within the tissue, it is referred to as ‘‘multicellular
streaming.’’ This occurs mainly when individual cells become
chemotactically attracted by a particular source or jointly follow
microtracks that are often present in peripheral connective
tissue (Kulesa and Gammill, 2010). In neoplasia, multicellular
streaming is often seen as chain- or swarm-like (i.e., diffuse)
tissue infiltration of many tumor cells in hematologic and solid
tumors (Kedrin et al., 2008).
Collective Invasion
Collective invasion requires cell-cell adhesion and multicellular
coordination to occur simultaneously with migration, which
results in multicellular groups and strands originating at the inter-
face between tumor and stroma (Friedl et al., 1995; Ilina and
Friedl, 2009). Collective invasion may adopt different morphol-
ogies, which depend on the cell type, the number of jointly
moving cells, and the tissue structure being invaded. For
instance, groups of cells can form small clusters, solid strands,
or files; if epithelial polarity is retained during migration, these
structures can even form an inner lumen (Friedl and Gilmour,
2009). In most cases of collective cancer invasion, one or several
leader cells with mesenchymal characteristics form the tip of
multicellular strands and generate forward traction and pericellu-
lar proteolysis toward the tissue structure (Gaggioli et al., 2007;
Khalil and Friedl, 2010). In a second type of collective invasion,
a blunt bud-like tip protrudes along tissue space consisting of
multiple cells that variably change position, lacking defined
leader cells (Ewald et al., 2008); this type of invasion occurs
preferentially in soft tissues and cells of strong epithelial
polarity. Collective migration is prevalent in morphogenesis
during development and recapitulated in most epithelial and
mesenchymal tumor types (Friedl and Gilmour, 2009; Friedl
et al., 1995).
Expansive Growth
Some surrounding tissues impose little to no physical confine-
ment on proliferating tumor cells and thus do not hinder the
expansion of a cancerous lesion. When tumor cells grow into
these tissues, the increase in volume leads to multicellular
outward pushing with intact cell-cell junctions and no signs of
active migration (Iguchi et al., 2008; Ishizaki et al., 2001). Eventu-
ally, this expansive growth without migration results in spherical
lesions within a ‘‘capsule’’ of ECM, formed by aligned collagen
fibers in circular orientation (Ishizaki et al., 2001). Expansive
growth may displace cells by volume expansion and pushing
when migration activity is absent or, if coupled with migration,
contributes to and enhances collective invasion (Ilina et al.,
2011) (B. Weigelin and P.F., unpublished data).
Although these migration modes can be classified as morpho-
logic and mechanistic entities for experimental and conceptual
purposes, cells often display features from multiple modes in
three-dimensional (3D) tissues. This includes intermediate or
transition states in which cells may change their molecular
profiles and switchmigrationmode (e.g., fromproteolytic to non-
proteolytic migration or single-cell to collective migration) (Friedl
andWolf, 2010; Wolf et al., 2003a). For example, when individual
cells become attracted by the same chemotactic source, they
may first undergo multicellular streaming with short-lived cell-
cell junctions that briefly form and resolve again; when cell-cell
adhesion molecules are then upregulated, the cells may join
each other and convert to a collective migration mode (Kulesa
and Gammill, 2010). Thus, diverse molecular programs jointlydetermine the morphology and mechanism by which normal
and neoplastic cells move through tissues.
Physical and Molecular Determinants of Invasion
The molecular mechanisms underlying each migration mode
depend on a set of connected mechanical and signaling path-
ways, which vary in their coordination and strength depending
on the particular migration mode. Such variations include the
organization of the cytoskeleton; the capability to remodel tissue
structures; and the type, strength, and turnover of cell-substrate
adhesions, cell-cell adhesions, and intercellular communication.
Stromal signals modulate all of these pathways through chemo-
kines, cytokines, and growth factors (Friedl and Wolf, 2010).
Different types of adhesion systems contribute directly or indi-
rectly to mechanocoupling between the actin cytoskeleton and
extracellular ECM (Figure 3A) or cell surface scaffolds (Fig-
ure 3B). Together, these adhesion systems govern migration.
ECM Receptors
Integrins are heterodimeric surface receptors composed of
a and b chains. Together, these chains mediate adhesion and
mechanotransduction to extracellular ligands, including a2b1
integrin predominantly binding to fibrillar collagen; aVb3, aVb1,
and a5b1 interacting with fibronectin; and a3b1 and a6b1
engaging with laminin (Hynes, 2002). After associating with
ligands, the cytoplasmic tails of integrins connect to cytoskeletal
adaptor proteins, including talin, paxillin, and kindlin and the me-
chanosensing modulators vinculin and p130Cas (Geiger et al.,
2009; Grashoff et al., 2010). Adaptor and mechanosensing mod-
ulator proteins engage with the actin cytoskeleton and trigger
signaling to protein kinases, including the focal adhesion kinase
(FAK) and Src (Geiger et al., 2009; Hodivala-Dilke et al., 1999;
Hynes, 2002). Downstream integrin effectors further include
the small GTPases Rac and Rho, which reinforce cell protrusion
and rear contraction (Ridley et al., 2003). In addition to contact
to ECM substrate, integrin engagement with extracellular
ligands is also activated by inside-out signaling through Rac,
the Ras-related GTPase Rap1, and talin (Lee et al., 2009; Ridley
et al., 2003).
CD44 and its alternatively spliced variants bind to hyaluronic
acid (i.e., a high-molecular weight glycosaminoglycan abun-
dantly present in all connective tissues) and, with low affinity,
to heparan sulfate, collagen, and fibronectin (Zo¨ller, 2011).
CD44 connects to the actin cytoskeleton by the adaptor proteins
ezrin, radixin, andmoesin (ERM) and ankyrin and mediates intra-
cellular signaling through Src kinase and small Rho GTPases,
including RhoA (Zo¨ller, 2011). CD44 and its splice variants also
bind to chemokines and growth factors, and they enhance
signaling through cis interactions with growth factor receptors,
including the hepatocyte growth factor receptor (c-Met), fibro-
blast growth factor (FGFR-1), the epidermal growth factor recep-
tors (EGFR), and its variants ERBB2–4. Thus, CD44 delivers joint
ECM and growth factor signaling to invading cells (Couchman,
2010; Zo¨ller, 2011). CD44 also serves as a coreceptor for other
adhesion receptors, including integrins and podoplanin (Zo¨ller,
2011). Podoplanin is a cell surface mucin that connects to the
actin cytoskeleton through ezrin. Podoplanin signals to enhance
RhoA activity, which strongly increases cell invasion (Martı´n-Vil-
lar et al., 2006; Wicki et al., 2006). Given its extensive crosstalkCell 147, November 23, 2011 ª2011 Elsevier Inc. 995
Figure 3. Molecular Determinants of Cell Migration
Simplified view of molecules mediating adhesion and migration signaling.
(A) Cell surface receptors and adaptors thatmediate the dynamic interface between the actin cytoskeleton and promigratory signaling and the extracellular matrix
(ECM).
(B) Cell surface proteins that mediate and regulate interactions between cells. Similar adhesion mechanisms may mediate homotypic cell-cell cohesion during
collective invasion and transient and more dynamic heterophilic interaction to resident tissue cells encountered during tissue invasion.
(C) Protease systems upregulated in cancer progression, invasion, and metastasis.
(D) Receptors for chemokines, cytokines, and growth factors, which sense soluble, ECM-, or proteoglycan-bound factors and interaction partners. Green
symbols represent selected intracellular adapters to the actin cytoskeleton, as specified below the drawing (A and B); shaded labels represent major signaling
molecules regulating actin organization and cell migration.with other receptor/ligand systems, it is unclear whether CD44
serves as bona fide adhesion receptor that mediates adhesion
and mechanotransduction in the absence of other pathways or
whether its primary role is to provide cosignaling (Maaser
et al., 1999).
Similar to CD44, membrane-bound proteoglycans, such as
syndecans, glypicans, and neuropillin, interact through their
sugar moieties weakly with ECM components, including hyalur-
onic acid, fibronectin, collagen, or elastin. These interactions
enhance adhesion in cooperation with integrins, and together
with integrins and growth factor receptors, the proteoglycans
deliver signals via PKC and Src (Couchman, 2010; Theocharis
et al., 2010). Syndecans-2 and -4 engage with ezrin or a-actinin,
respectively, and they couple to the actin cytoskeleton.
However, their direct contributions to adhesion and migration
are still unclear (Couchman, 2010).
The discoidin domain receptors DDR1 and DDR2 interact
selectively with fibrillar collagen and transmit signaling via
STAT5, NFkB, and p38 MAPK/ERK or the Src-related kinases
Syk, Shc, and Src, respectively (Neuhaus et al., 2011; Vogel996 Cell 147, November 23, 2011 ª2011 Elsevier Inc.et al., 2006). DDRs support E- and N-cadherin-mediated cell-
cell adhesion (Eswaramoorthy et al., 2010; Shintani et al.,
2008), and they increase proteolytic cell functions viamatrixmet-
alloproteinases (MMPs), includingMMP-1, MMP-2, MMP-9, and
MMP-10 (Ruiz and Jarai, 2011). The signaling activity of DDRs
after they bind to the ECM is well established; however, whether
DDRs connect to the actin cytoskeleton and directly contribute
to mechanotransduction is unknown.
Integrins are thus the main adhesion and mechanotrans-
duction system for interstitial migration, with modulatory input
and crosstalk to alternative cell-ECM and growth factor sig-
naling systems through CD44, cell surface proteoglycans, and
DDRs.
Cell-Cell Adhesion Receptors
Receptors that transmit cell-cell adhesion forces toward the
actin cytoskeleton provide cooperation between tumor cells
during collective invasion (Giampieri et al., 2009; Ilina and Friedl,
2009). These receptors also support single-cell and collective
movement along the surfaces of other tissue-resident cells
encountered during the migration process (Figure 3B).
Members of the cadherin family of adhesion receptorsmediate
homotypic interactions between cells of the same type and
heterotypic interactions between different cell types. These
interactions include stable cell-cell adhesion through adherens
junctions (Harris and Tepass, 2010), dynamic adhesion via the
transient co-engagement of small GTPases Rac1 and RhoA,
and dynamic junctional remodeling by cytoskeletal dynamics
(Kardash et al., 2011). In both stable and dynamic cell-cell
adhesion, cadherins engage with cytoskeletal adaptor and sig-
naling proteins, including a-catenin, b-catenin, and p120-cate-
nin, which connect to the actin and microtubule cytoskeleton
(Berx and van Roy, 2009; Harris and Tepass, 2010; Reynolds,
2010).Dependingon the typeof tumor, different sets of cadherins
are expressed and involved in cell-cell interaction, including E-,
N-, and P-cadherins, cadherin-11, and cadherin-13 (Berx and
van Roy, 2009). In polarized resting epithelium, E-cadherin
suppresses migration signaling by inhibiting Rac1 (Kitt and
Nelson, 2011) and further maintains cell-cell cohesion, polarity
between the basal and luminal layer of an epithelium, and epithe-
lial stability. In contrast, in activated and neoplastic epithelium,
E-cadherin and other cadherins jointly coordinate collective
movements (Friedl and Gilmour, 2009). In activated epithelial
cells, cosignaling of E-cadherin and integrins, together with
downstream Src activation, enhances actin dynamics and acto-
myosin contractility, leading to both single-cell and collective
migration (Geisbrecht and Montell, 2002; Kardash et al., 2010;
Martinez-Rico et al., 2010). When co-engaged with DDR1, E-
cadherin signaling limits actomyosin contractility along cell-cell
junctions, which stabilizes cell-cell junctions and supports
collective invasion (Hidalgo-Carcedo et al., 2011). Compared to
E-cadherin, N-cadherin and cadherin-7 mediate weaker adhe-
sion strengths (Chu et al., 2006) and are associated with further
increased motility in cancer. This enhanced motility is most
likely due to N-cadherin and cadherin-7’s co-engagement with
growth factor receptors, including FGFR or PDGFR, which
enhances downstream signaling through MAPK and PI3K (Berx
and van Roy, 2009). Thus, cadherins show duality in delivering
both migration-inhibiting and migration-promoting signaling in a
context-dependent manner (Martinez-Rico et al., 2010).
The immunoglobulin superfamily of cell adhesion molecules
(CAM) mediates homophilic cell-cell interactions in neoplastic
cells through the direct or indirect coupling to the actin cytoskel-
eton via actin-binding adaptor proteins a-actinin, ankyrin, and
ezrin (Gavert et al., 2010; Maness and Schachner, 2007). This
family of adhesionmolecules includes L1CAM, EpCAM, NCAMs,
or ALCAM.
L1CAM is upregulated in the leading front of collectively
invading epithelial tumors that display a stabilized mesenchymal
phenotype with high invasion capability (Bergmann et al., 2010;
Hung et al., 2010). This is consistent with a role for L1CAM in
leader-cell function and partial EMT during collective invasion
(Gavert et al., 2011). Likewise, ALCAM is upregulated in cell-
cell junctions of collectively invading epithelial cancer associated
with increased metastasis (van den Brand et al., 2010).
Similar to leukocytes, tumor cells develop heterophilic cell-cell
interactions with endothelial cells and platelets that express
ICAM-1, VCAM-1, or PECAM-1. These interactions occur
through b1 and candidate integrins b2, aVb3, and a4b7 ex-pressed by the tumor cells and mediate intravascular migration
and adhesion arrest of circulating tumor cells (Hynes, 2002; Sto-
letov et al., 2010). Integrins may further engage with ECM
proteins tethered and immobilized on encountered cell surfaces
(e.g., fibronectin and laminin) and mediate cell-cell adhesion
between tumor cells (Casey et al., 2001).
Besides mechanocoupling, CAMs enhance the signaling
of integrins and growth factor receptors (e.g., EGFR and
FGFR) through ERK, ILK, or Src (Kiefel et al., 2011; Zecchini
et al., 2011). Their contributions to homotypic interaction
between tumor cells and heterotypic interactions between
tumor and stromal cells make CAMs versatile mechanotrans-
duction and signaling devices in both single-cell and collective
invasion.
Several other receptor families contribute to cell-cell contacts
and multicellular coordination. These include connexins that
form gap junctions (Li et al., 2008), as well as ephrins and Eph
receptors. Ephrins and Eph receptors weaken homotypic and
heterotypic binding by engaging with alternative sets of ephrins
expressed by neighboring tumor and stromal cells (Astin et al.,
2010), thereby contributing to tumor cell guidance and migration
in a tissue context-dependent manner.
Overall, tumor cells engage in a variety of overlapping and
synergistic cell-matrix and cell-cell adhesion systems that
balance cell-cell cohesion within the tumor and cohesion toward
stromal interfaces.
Protease Systems
In both tumor and stromal cells, multiple protease systems are
upregulated with overlapping substrate specificities. These
systems includeMMPs, ADAMs, cathepsins, the serine protease
urokinase plasminogen activator (uPA), and its receptor uPAR
(Mason and Joyce, 2011; Rizki et al., 2008) (Figure 3C). Upregu-
lated proteases contribute to tumor invasion and progression
through at least three distinct mechanisms (Egeblad and Werb,
2002; Wolf and Friedl, 2011).
First, cell surface proteases, notably membrane-type (MT)
MMPs and ADAMs (a disintegrin and metalloproteinases),
execute contact-dependent proteolysis of structural ECM
proteins, including fibrillar and nonfibrillar collagens, fibronectin,
and laminins, as well as ECM-tethered, matricellular proteins
(e.g., tenascin and glypican) (Sabeh et al., 2004, 2009; Wolf
et al., 2007). Proteolytic ECM degradation has a dual function:
(1) it generates biologically active epitopes of ECM components
with adhesion- or migration-promoting effects (Kenny et al.,
2008), and (2) it structurally remodels tissue to form de novo
gaps and trails bordered by multifiber ECM bundles (Gaggioli
et al., 2007; Sabeh et al., 2009; Wolf et al., 2007).
Second, proteases that are secreted and tethered to the cell
surface, notably MMPs and ADAMs, enzymatically process
other proteases and cell surface receptors, including adhesion
and growth factor receptors (Overall and Blobel, 2007). This
controls the activation and turnover of these receptors and
thus accounts for adaptive changes of receptor availability on
both tumor and stromal cells and interstitial protease content.
Finally, secreted proteases, particularly MMPs and plasmin,
regulate the repertoire of available extracellular growth factors
by enzymatic activation, inactivation, or degradation (Dean et al.,
2008; Mu et al., 2002; Sounni et al., 2010). MMPs and ADAMsCell 147, November 23, 2011 ª2011 Elsevier Inc. 997
can release ECM-bound factors, which then form diffusing
gradients toward neighbor cells (Shiao and Coussens, 2010).
Thus, the proinvasive tumor microenvironment dominated by
proteases consists of both structural ECM remodeling sup-
ported by pericellular proteolysis and deregulated proteolytic
processing of chemokines, growth factors, and their receptors,
which impacts both tumor and stromal cells.
Chemokines, Growth Factors, and Their Receptors
The transition from a fixed, tissue-anchored state to a mobile
state is often induced by extracellular chemokines, cytokines,
and growth factors released by tumor cells themselves or acti-
vated stromal cells. These factors engage redundant and nonre-
dundant intracellular signaling networks in both tumor and
stromal cells (Figure 3D). Invasion-promoting chemokines
include CXCL12, CXCL10, CCL21, or CCL25. They mediate
and perpetuate invasive migration of tumor cells in the primary
tumor and likely during metastatic dissemination (Allinen et al.,
2004; Zlotnik et al., 2011). Migration-promoting signals induced
by chemokines and their receptors CXCR4, CXCR3, and CCR9
are mainly mediated by JAK/PI3K/JNK, PI3K, Src-family kinase
Syk, and the small GTPases Rac1, RhoA, and Rap1 (El Haibi
et al., 2010; Lee et al., 2009; Tybulewicz and Henderson,
2009). Besides their control on the cell cycle and cell survival,
many growth factors, includingHGF, EGF, FGF, and TGFb, share
signaling through ERK, JNK, Src, mTOR, and PI3K pathways
toward Rac and Cdc42 activation and enhanced cytoskeletal
dynamics (Massague´, 2008; Shapiro et al., 2011; Trusolino
et al., 2010). Because of their pleiotropic effects, promigratory
conditioning of the tumor-associated tissue increases: (1) the
invasion and dissemination of tumor cells; (2) the motility and
activity of stromal cells, including fibroblasts and macrophages;
(3) the recruitment and transendothelial migration of circulating
leukocytes and precursor cells into the tumor stroma; and (4)
the mobilization of bone marrow-derived cells into the circu-
lation through systemic growth factor effects in other organs,
including the bone marrow (Orimo et al., 2005; Padua and Mas-
sague´, 2009; Roussos et al., 2011; Zlotnik et al., 2011).
Thus, multiple overlapping adhesion and signaling networks
cooperate toward molecular and structural reorganization of
contacted tissues and support tumor cell invasion and meta-
static dissemination.
Heterogeneity of Invasion Routes
In vivo, cancer invasion and metastatic dissemination depend
upon two interconnected complementary cell escape strategies.
The first and simplest strategy is the movement of cells along
pre-existing tissue structures in which the available space
matches or exceeds the volume of the cell or cell group. The
second strategy results from proteolytic breakdown of tissue
structures to generate de novo space required for invasion
(Wolf et al., 2009; Wolf and Friedl, 2011).
Guidance Structures in Tissues
Recently, two-dimensional (2D) and 3D microscopy have map-
ped the structural organization of tissues during cell invasion,
and intravital microscopy has been used to examine experi-
mental tumors in vivo (Pittet and Weissleder, 2011 [this issue of
Cell]). These approaches, combined with histopathological
analysis of human tumors, strongly suggest that both single-998 Cell 147, November 23, 2011 ª2011 Elsevier Inc.cell and multicellular tumor invasion are guided and supported
by pre-existing structures and interfaces present in every tissue
(Alexander et al., 2008; Condeelis and Segall, 2003; Grytsenko
et al., 2011; Schedin and Keely, 2011) (Figure 4). Conceptually,
tissue structures that guide invasion can be categorized as
‘‘2D’’ and ‘‘3D’’ depending onwhether cells adhere to a substrate
on one or several sides. 2D surfaces, with even or irregular
conformation, form nearly barrier-free track-like gaps and trails
that typically contain interstitial fluid and glycosaminoglycans.
In vivo, most 2D surfaces are encountered in a 3D context,
such as a second opposing surface, or a nearby 3D scaffold;
therefore, with the notable exception of adherence to the wall
of a larger vessel, cell invasion is, in most cases, constitutively
three dimensional.
Inner-body surfaces are always covered with an epithelium or
endothelium layer, and thus, interacting cells depend upon cell-
cell rather than cell-matrix interactions. 2D cell surfaces include:
the peritoneum covering all internal organs; the pleura covering
the lungs and thorax wall; the ventricles of the brain; and inner
surfaces of larger blood and lymph vessels (Figure 4A). Viewed
from a cell mechanics angle, cell surfaces allow for highly effec-
tive, almost barrier-free dissemination of tumor cells. This is
observed during peritoneal or pleural carcinosis in which tumor
and other cells readily spread centimeters, likely by both active
migration and migration-independent passive drift (Zecchini
et al., 2011).
When viewed at microscopic resolution, connective tissue is
not a uniform, homogeneous meshwork of ECM, but rather, it
is composed of nonrandom structures, including discontinuities
formed by surface-like gaps and tracks. The anatomic function
of these gaps and tracks is likely transportation of tissue fluids,
tissue elasticity, and mechanical sliding of tissue components
relative to each other. 3D tracks with bordering 2D interfaces
are formed by larger anatomic structures covered by a basement
membrane, including small blood vessels, myofibers, nerve
tracks, and adipocytes (Figure 4B). Similar longitudinal tracks
are formed by bundled 3D collagen fibers (Figure 4C). These
‘‘inner surfaces’’ likely correspond anatomically to narrow clefts
(‘‘shrinkage artifacts’’) that are abundantly present in virtually
every tissue after fixation and, when reconstructed three
dimensionally, display a 3D track system (O. Ilina and P.F.,
unpublished data) along and between fibrillar interstitial tissue
structures. In cancer lesions and tumor xenografts monitored
by 3D intravital microscopy, these interfaces are often used by
invading cells with little sign of structural alteration or degen-
eration (Alexander et al., 2008; Condeelis and Segall, 2003).
Other tissue-specific guidance structures preferentially used
by metastasizing cells are bone cavities, which are covered by
a monolayer of lining cells, and the perivascular tracks in brain
vessels formed between glial cells and the basement membrane
of vascular smooth muscle cells (Figure 4D). Another special
case of barrier-free dissemination is the lumen of small vessels,
which provide a tube-like track for rapid intravascular dissemina-
tion of cancer cells through capillaries in peripheral tissue and
liver sinusoids (Tsuji et al., 2006) (Figure 4A).
Lastly, 3D scaffolds composed of randomly organized fibrin
and collagen fibrils provide a combination of 1D (the string-like
linear fiber) and 3D scaffold with pores of complex geometry
Figure 4. Anatomic Tissue Structures Guiding Cancer Invasion
(A) Epithelial and endothelial surfaces devoid of ECM.
(B) Basement membranes interfacing with the ECM between cells and tissues.
(C) Collagen-rich interstitial scaffolds of compact or loose structure and organization.
(D) Complex interfaces composed of both cell surfaces and ECM scaffolds. Solid multimeric scaffold structures interface with tissue pores and track-like gaps
(cyan).(Doyle et al., 2009; Wolf et al., 2009) (Figure 4C). Such ECM
networks are predominant in loose connective tissue, such as
the dermis of young mice, provisional tissue such as a fibrin
clot after tissue wounding, and as largely ECM-free tracks
(formed by astrocytes and neuronal fibers) the white matter of
the brain (Grytsenko et al., 2011; Wolf et al., 2009). Thesenetworks are similar to in vitro-reconstituted 3D collagen
matrices or basement membrane equivalents frequently used
for cell invasion research.
Invading cells are thus required to accommodate diverse
geometries and molecular ligand systems for adhesion and
migration in vivo. Whereas in vitro-reconstituted ECM models,Cell 147, November 23, 2011 ª2011 Elsevier Inc. 999
due to their cell-independent polymerization process, mimic
random ECM structures, complex cell and tissue engineering
is needed to recapitulate the multicomponent complexity of 2D
interface-based track geometries of guiding scaffolds in vivo
(Ilina et al., 2011).
Molecular Guidance Cues
Physical space is likely translated into directed cell polarity and
cytoskeletal dynamics through receptor-mediated molecular
recognition of the adjacent scaffold structure. Invading cancer
cells often simultaneously integrate signals from: (1) ECM mole-
cules, including collagens, laminins, fibronectin, and elastin; (2)
cell surfaces, including cadherins, CAMs, and proteoglycans;
and (3) gradients of promigratory factors, i.e., chemotactic
(soluble factors) and haptotactic gradients (ECM-bound factors).
Molecular sensing through adhesion and chemotactic receptors
directs tumor cell migration to mediate chemotaxis and hapto-
taxis (i.e., directional moltility along a gradient of cell adhesion
sites or substrate-bound chemoattractants) jointly with physical
contact guidance, which is often tissue context dependent.
Besides the physical scaffold structure, the ECM guidance of
invading cells is mediated by covalently and noncovalently
associated accessory components deposited by stromal cells.
Guidance by ECM
The molecular and physical characteristics of the ECM strongly
contribute to cell adhesion, migration, and cell fate decisions
with consequences for cancer cell invasion and dissemination.
The quantitatively most abundant and important component of
connective tissue is collagen type I, which serves as structural
frame for cells and other scaffold proteins (Grytsenko et al.,
2011; Wolf et al., 2009). In the activated tumor stroma, the
density of collagen fibers is often increased (i.e., desmoplasia),
and hyaluronan, proteoglycans, and glycoproteins (e.g., fibrin,
fibronectin, and vitronectin) become upregulated. Together
these molecules decorate and ‘‘functionalize’’ the collagen scaf-
fold. In vitro, mesenchymal fibroblasts and cancer cells migrate
along 2D or through 3D collagen using a2b1, a1b1, or a11b1 in-
tegrins and a5b1, aVb3, and aVb5 for migration along or through
fibrin or fibronectin scaffolds (Even-Ram and Yamada, 2005;
Maaser et al., 1999).
Integrins alsomediate themigration of normal and cancer cells
along structural components of basement membranes by
engaging with collagen type IV (a1b1, a2b1), laminins (a3b1,
a6b1), fibrillin (a5b1, aVb3, aVb6), perlecan, and versican (b1)
(Hynes, 2002). Consequently, perivascular invasion of glioma
cells and perineural invasion of pancreatic cancer cells are linked
to the function of laminin-binding b1 integrins (Piao et al., 2009;
Ryschich et al., 2009), but the mechanisms of other basement
membrane-dependent routes, including peri- and intramuscular
guidance and adipose tissue invasion, are unknown.
Most ECM proteins undergo enzymatic postprocessing by
cell-derived proteases (Figure 3C) or crosslinking proteins.
Fibrillar collagens become glycosylated and crosslinked by lysyl
oxydases (LOX) and lysyl hydroxylases, which increases
collagen stiffness and resistance to assault by pH changes and
proteolytic degradation (Levental et al., 2009; Paszek et al.,
2005). Normal and neoplastic cells sense differences in physical
ECM properties and migrate preferentially toward regions of
increased stiffness, termed durotaxis (Lo et al., 2000). Stiff1000 Cell 147, November 23, 2011 ª2011 Elsevier Inc.substrate enhances and reinforces the clustering of integrins
and the secondary formation of focal adhesions and cytoskeletal
linkages through the adaptor proteins p130Cas and vinculin
(Grashoff et al., 2010; Sawada et al., 2006). This augments
both cell contractility and mesenchymal functions (Levental
et al., 2009).
Consequently, the upregulation of peri-tumor collagen
production favors cancer cell invasion and metastasis in breast
and other cancer models (Goetz et al., 2011; Levental et al.,
2009; Paszek et al., 2005). Besides modulating cell invasion,
the physical tissue properties determine the fate of normal cells
with consequences for cell growth and differentiation (Discher
et al., 2005). As a central downstream signaling pathway that
connectsmechanotransduction to gene expression, cell prolifer-
ation in response to substrate stiffness is regulated by Yap1, a
transcription factor downstream of the hippo pathway (Dupont
et al., 2011). Yap1 engagement supports epithelial stem cell
growth and hyperproliferation, which is counteracted by
signaling through a-catenin (Schlegelmilch et al., 2011). Thus,
Yap1 represents an important mechanosensitive candidate
effector for neoplastic progression in cells with deregulated cad-
herin/catenin axis.
Guidance along Cell Membranes
Besides cell-ECM interactions mediating cell migration, an
understudied but emerging mechanism is the guidance by cell-
cell junctions. Besides the epithelium covering inner-body cavi-
ties and endothelium forming the lumen of blood and lymph
vessels, intermittent and likely discontinuous cell scaffolds are
abundant in most tissues, including fibroblast networks, macro-
phages, and epithelial structures (Figure 4). In developing zebra-
fish, primordial amoeboid germ cells migrating individually
through a cell-rich tissue scaffold employ E-cadherin and Rho-
mediated actomyosin contraction for migration (Kardash et al.,
2011). The small group of germ cells of the developing
Drosophila ovary, called border cells, provides an example of
collective migration mediated by E-cadherin. These cells are
connected by E-cadherin, guided by EGF, and depend upon
E-cadherin for migration (Geisbrecht and Montell, 2002). Cell-
cell junctions thus represent an alternative mechanotransduc-
tion mechanism for migration, when cell-matrix adhesions are
downregulated or absent. However, though effective in morpho-
genesis, the role of cadherin-based cell-cell interactions in tumor
cell invasion is still unclear.
Secreted Guidance Molecules
Many chemokines and growth factors contain one or several
ECM-binding domains, which immobilize the factors in tissues,
thereby forming a stable promigratory scaffold. Chemokines
and growth factors contain binding sites to heparan sulfate
side chains (Lortat-Jacob et al., 2002) that are present in intersti-
tial and cell surface proteoglycans and heparin (Hynes, 2009).
After functionalization, a scaffold contains both adhesion sites
(for integrins and other receptors) and immobilized migration-
inducing signal (via CCR or GFR) on the same geometric struc-
ture, such as a fibril or basement membrane, to support cell
protrusions and adhesion in close vicinity along the same
substrate. In 3D invasion models of branching morphogenesis,
which support collective sprouting of epithelial ducts of the
mammary or salivary gland, immobilization of FGF10 to heparan
Figure 5. Plasticity of Cell-Matrix Interaction, Invasion, and Tissue Remodeling
(A) Migrating cells transition from an initial nondestructive dissemination to migration that involves small- and large-scale tissue remodeling. The pre-existing
space available to invading cells governs the caliber of individual and multicellular invasion and becomes iteratively widened by pericellular proteolysis.
(B) Epithelial-to-mesenchymal transition of a stable epithelium after downregulation of cell-cell junctions and facilitated single-cell detachment.
(C and D) Invasion programs display plasticity, or adaptability, including transition from collective cell migration to individual cell migration (C) and mesenchymal-
to-amoeboid transition (D). Key regulators of these transitions altered in expression or function are indicated.sulfate maximizes duct elongation and growth by engaging
FGFR2 signaling; in contrast, a diffusion-only variant of FGF10
lacks the proinvasive function and supports only growth (Makar-
enkova et al., 2009). Likewise, the chemokine CXCL12/SDF-1
and EGF interact with interstitial heparan sulfate and form stable
gradients that guide migrating tumor cells and passenger leuko-
cytes (Allinen et al., 2004; Netelenbos et al., 2002; Wyckoff et al.,
2004).
TGFb is a master inducer of mesenchymal invasion and stem
cell functions in cancer cells. It is immobilized to the ECM via
fibronectin and fibrillin by latent TGFb-binding proteins and
becomes released through limited proteolysis mediated by
MMPs or furin that are activated and released by activated
stromal cells (Mu et al., 2002). Alternatively, integrins bind to
latent TGFb-binding protein complexes and pull to induce a
conformational change that is required to make ECM-bound
TGFb accessible for its receptors (Wipff et al., 2007). Osteopontin
is a secreted cytokine-like proteoglycan that binds to CD44 and
integrins. Osteopontin is upregulated in many tumor types and
strongly supports invasive cell guidance (Bellahce`ne et al., 2008).
In addition to these examples, gene expression profiling and
proteomics have revealed abundant sets of soluble factors and
ECM proteins upregulated in the microenvironment of tumors,
indicative of complex signaling pathways induced in both tumor
and stromal cells (Allinen et al., 2004; Wang et al., 2004). Besides
their local peri-tumor function, many deposited factors diffuse
into blood and lymphatic fluid, which unfolds systemic,
hormone-like functions. CXCL12/SDF-1 and osteopontin are
important examples of these soluble factors. Tumor-derived
CXCL12/SDF-1 mobilizes bone marrow stem cells that becomerecruited into the tumor and contribute to the formation of tumor
blood vessels (Orimo et al., 2005), and osteopontin activates
bone marrow-derived cells that integrate into the tumor and
accelerate tumor outgrowth (McAllister et al., 2008).
Thus, multiple and partially overlapping mechanisms
contribute to the mechanical and molecular guidance of tumor
cells, but their crosstalk and hierarchy still remain unknown.
Plasticity of Invasion and Metastasis Programs
Together, the different modes of cancer cell invasion, the recep-
tors and cytoskeletal regulators available for cell-cell and cell-
matrix adhesion, the divergent degree of ECM remodeling capa-
bility, and the range of invasion-guiding molecular and physical
tissue environments provide amultiscale framework of combina-
torial possibilities or states that allow cancer invasion to be
a plastic and adaptive process (Friedl, 2004; Friedl and Wolf,
2010). Consequently, with altered tissue composition and condi-
tioning by released factors, tumor cells undergo changes in
signaling and function that lead to secondary effects in the
invaded tissue and, in turn, the tumor cells themselves.
Plasticity of Tissue Structures
Interstitial cancer cell invasion occurs in different phases that
can be labeled operationally as an initial, nondestructive guid-
ance phase, followed by a phase of tissue remodeling. In a step-
wise manner, invasive migration leads to the production of
pores, tunnels, and lagunae, which guide and can be populated
by mobile tumor cells (Alexander et al., 2008; Condeelis and
Segall, 2003) (S.A., unpublished data) (Figure 5A). With upregu-
lated MMPs, most notably MT1-MMP/MMP14, pericellular
proteolysis executed by tumor cells themselves or fibroblastsCell 147, November 23, 2011 ª2011 Elsevier Inc. 1001
generates micro- and macrotracks bordered by condensed
ordered collagen bundles, which strongly support both single-
cell and collective invasion (Friedl et al., 1997; Gaggioli et al.,
2007; Goetz et al., 2011; Wolf et al., 2007) (Figure 5A). These
de novo tracks guide tumor cells and, with pressure exerted by
the invading cells, become gradually widened until the tissue
space consumed by invading cell masses matches the regres-
sion of the ECM (Gaggioli et al., 2007; Ilina et al., 2011; Wolf
and Friedl, 2011). Such trails, often filled by tumor cells, are
abundant in most interstitial collagen-rich tissues, including des-
moplastic stroma (Levental et al., 2009; Paszek et al., 2005).
Thus, despite its increased absolute collagen density, the
signals, gaps, and trails present in desmoplastic stroma enhance
cancer invasion and progression rather than acting as barrier.
By direct and indirect mechanisms, desmoplastic tissue
remodeling is a strong mediator of neoplastic progression, inva-
sion, and metastasis (Egeblad et al., 2010). As key mediators of
desmoplasia, resident fibroblasts and immigrated fibroblast
precursor cells receive activation signals through growth factors,
including TGFb, IL-1, and PDGF. They then develop into cancer-
associated myofibroblasts (CAF) that deposit, remodel, and
contract fibrillar collagen (De Wever et al., 2008; Egeblad et al.,
2010). As a physiological process of the connective tissue reor-
ganization, the postpartum involution of the mammary gland
leads to the deposition of fibrillar collagen and collagen-induced
release of proinflammatory COX-2 (Lyons et al., 2011). This
reorganization is sufficient to impose growth, invasion as multi-
cellular strands and metastasis programs in otherwise benign
or less aggressive breast tumor lesions (Lyons et al., 2011). A
similar progression of breast cancer is triggered by activated
fibroblasts that reorganize and condense the breast stroma to
aligned, bundled collagen tracks that condition breast cancer
invasion and metastasis (Goetz et al., 2011).
In bone metastases, bone resorption is executed by osteo-
clasts in which RANKL (receptor activator of NF-kB ligand) is
activated by a TGF-b and MMP13-dependent mechanism;
this allows the growing tumor to expand into de novo space,
which eventually results in local bone destruction (Nannuru
et al., 2010; Nannuru and Singh, 2010). In all cases, pre-existing
tissue space is first filled by invading cells without apparent
degradation, and then, with increasing cell density and the upre-
gulation of MMPs and other proteases, the tissue is degraded
and reorganized. As an outcome, cancer invasion leads to
secondary loss of tissue integrity and function, including tissue
necrosis, ulceration, and vessel rupture. Accordingly, the struc-
tures detected by histology represent statically looking snap-
shots of an otherwise dynamic and plastic process by which
the growing and invading tumor replaces and eventually
destroys interstitial tissue.
Plasticity of Cell-Cell Junctions:
The Epithelial-to-Mesenchymal Transition
A central molecular program enhancing tumor cell invasion in
response to environmental triggers is the epithelial-to-mesen-
chymal transition (EMT). EMT initiates or augments invasive
functions by enhancing Rac-dependent mesenchymal migra-
tion. It also contributes to cell growth, cell survival, and the ree-
mergence of stem cell characteristics (Thiery et al., 2009)
(Figure 5B).1002 Cell 147, November 23, 2011 ª2011 Elsevier Inc.During EMT, upstream signals through growth factors of the
tumor stroma, including Wnt, TGFb, FGF, and EGF, lead to the
activation of transcriptional repressors, including ZEB1, Twist,
and Snail1 and 2, which directly and indirectly inhibit E-cadherin
transcription (Spaderna et al., 2008; Yang et al., 2004). For
example, in breast cancer cells undergoing EMT in response to
MMP-3 (which cleaves cell surface E-cadherin and thus
weakens cell-cell junctions), the onset of migration depends on
Rac activation and cell-derived production of reactive oxygen
species (ROS), which in turn upregulate Snail (Radisky et al.,
2005). With E-cadherin expression diminished, adherens junc-
tions and the signaling thereof are weakened or replaced by
less stringent cell-cell adhesions through N-cadherin or
L1CAM (Gavert et al., 2007; Yano et al., 2004). This results in
the disturbance of apicobasal polarity and cell anchoring to the
basement membrane, which, in turn, allows the cells to acquire
a mobile mesenchymal phenotype (Thiery et al., 2009). The
EMT program further favors a stem cell-like phenotype that
invades, disseminates, and is able to establish distant metas-
tases (Mani et al., 2008).
The induction of EMT with downregulation of E-cadherin
expression is likely tunable, dependent on whether complete
or partial EMT signaling is present. As consequence, EMT can
be complete with loss of E-cadherin and the typical EMT
signaling and protein expression profile. However, EMT may
be partial with different levels of E-cadherin expression retained,
and even EMT-like dissemination without EMT-associated gene
expression patterns may develop (Christiansen and Rajase-
karan, 2006; Gavert et al., 2011; Pa`ez-Ribes et al., 2009; Wicki
et al., 2006). In epithelial cancer lesions, EMT is detected in
a few often cohesive cells located at the leading edge, as well
as small cohesive groups and individual cells scattered and
moving independently without connection to the main tumor
(Brabletz et al., 2001; Gavert et al., 2007). Thus, besides repre-
senting a program for complete loss of cell-cell junctions, EMT
further may contribute to collective cell functions, including
collective invasion. This is consistent with the prominent collec-
tive invasion of primary mesenchymal tumors and melanoma
(Alexander et al., 2008; Hegerfeldt et al., 2002).
EMT is also thought to represent a program transiently
controlled by the microenvironment, which locally downregu-
lates epithelial characteristics and facilitates cell escape from
the primary tumor. However, with local upstream signaling lost,
cells undergo mesenchymal-to-epithelial reversion after meta-
static seeding in the secondary organ (Spaderna et al., 2006;
Thiery et al., 2009). Thus, EMT-dependent invasion and metas-
tasis programs are strongly responsive to microenvironmental
changes and adaptive in their signaling program and associated
invasion dynamics.
Plasticity of Cell-Matrix Interactions
and Cytoskeletal Dynamics
The executive mechanotransducing mechanisms of cell migra-
tion are plastic and allow the rapid adaptation to environmental
changes and challenges; these adaptations often result in transi-
tions between different modes of migration (Friedl and Wolf,
2010; Sanz-Moreno and Marshall, 2010). Such plasticity likely
originates in response to tissue microregions and responses to
therapeutic challenge. The natural regulation of gene expression
and signal states in tumor cells by the microenvironment thus
accounts for the often heterogeneous invasion pattern in
progressing tumor lesions. In addition, diversity of persisting
invasion is caused by rewiring of signaling networks and differ-
ential cell survival during tissue damage and therapy (Alexander
and Friedl, 2012).
In collectively invading tumors, cell-cell coordination and
signaling are mediated by either E-cadherin expressed at levels
that do not confound the migration process or alternative cad-
herins, including N- or VE-cadherin (Yano et al., 2004) (Fig-
ure 5C). Mechanisms of collective invasion with expressed
E-cadherin in cell-cell junctions include the upregulation of:
L1CAM, which strongly promotes migration (Gavert et al.,
2011; Shtutman et al., 2006); the guanin nucleotide exchange
factor Tiam-1, which activates Rac1 but maintains adherens
and tight junctions (Mertens et al., 2005; Walch et al., 2008); or
podoplanin, which increases RhoA activity in the presence of
E-cadherin-based adhesions (Wicki et al., 2006).
Similar to the EMT program, the transition from collective cell
migration to individual cell migration (i.e., the collection-to-
individual transition) is triggered by local Rac1 engagement,
allowing for ectopic tip cell behavior, substrate engagement,
and eventually, cell detachment (which is facilitated by down-
regulation of cadherin-based cell-cell adhesion) (Figure 5C).
Environmental stimuli can favor single-cell detachment from
tumors, partly through EMT and partly in the absence of EMT
(Bertout et al., 2008; Pennacchietti et al., 2003). These stimuli
include TGFb, EGF, and other growth factors, but also metabolic
stress, such as acidification of the stroma causing a shift in tumor
metabolism (i.e., the Warburg effect) and hypoxia with reactive
HIF-1a signaling (Bertout et al., 2008; Pennacchietti et al., 2003).
Alternatively, amoeboid dissemination may originate from
collective invasion when cell-cell junctions are abandoned and
release the cells toward a single-cell migration program of low
integrin-mediated adhesion and high Rho-mediated cortical
actomyosin contractility (Hegerfeldt et al., 2002; Sanz-Moreno
et al., 2008). In breast cancer lesions, EGF secreted predomi-
nantly by activated macrophages activates and guides tumor
cells that have detached from the epithelial main mass by amoe-
boid dissemination (Wyckoff et al., 2004). Thus, the type of
migration maintained after detachment from the multicellular
state depends upon the governance of adhesion strength, cyto-
skeletal protrusions and contractility, and the competence to
remodel the ECM.
Mesenchymal invasion may undergo secondary conversion
to amoeboid, rounded migration by diverse mechanisms, such
as a decrease in Rac activity and concomitant activation of
Rho-mediated actomyosin contractility (Sahai and Marshall,
2003). The therapeutic inhibition of MMPs can also trigger
amoeboid migration because pericellular proteolysis by MMPs
prompts conversion to nonproteolytic amoeboid cell deforma-
tion to bypass narrow ECM barriers (Wolf et al., 2003a)
(Figure 5D). Likewise, amoeboid movement in otherwise mesen-
chymal cells is induced by inhibiting chemokine-meditated
Rac activation (Ge´rard et al., 2007), activating Rho by inhibiting
p190RhoGAP (Nimnual et al., 2003), or engaging EphA2 (an
indirect Rho activator) (Parri et al., 2009). Lastly, gene mutations
that impact integrin availability or the Rac/Rho balance maylead to plasticity of invasion and metastasis. Mutation or loss
of p53 leads to enhanced integrin turnover and recycling, which
converts cells to the amoeboid dissemination mode and
strongly enhances invasion/metastasis (Gadea et al., 2007;
Muller et al., 2009).
Thus, in context, with gain or loss of cell-cell junctions and
adaptive signaling control through Rac and Rho, cancer invasion
programs are plastic and responsive to microenvironmental
signals and molecular interference, which secures migration
under challenging conditions (Madsen and Sahai, 2010). These
basic conversion mechanisms have been established for
in vitro conditions using cell lines, and their relevance for tumor
lesions in vivo await confirmation by using 3D histopathology
combined with intravital imaging (Pittet and Weissleder, 2011).
Likewise, how invasion plasticity is connected with or distinct
from EMT programs remains to be shown in vitro and in vivo.
This will identify EMT-dependent and -independent routes and
niches of natural and therapy-induced plasticity of invasion
and their contribution to metastatic dissemination (Christiansen
and Rajasekaran, 2006).
Plasticity and Reciprocity—A Model
The mechanisms of spatiotemporal plasticity (i.e., to change
phenotype and function) and reciprocity (i.e., to do this by pro-
cessing signals received from the environment) are fundamental
to the step-wise changes in both tumor cells and the microenvi-
ronment, a process that receives further drift with cells moving
from one environment to another. The concept of dynamic reci-
procity for cells engaging with and thereby altering the ECMwas
originally coined by Paul Bornstein for cell-matrix interactions in
wound healing (Bornstein et al., 1982) andwas further developed
by Mina Bissell and coworkers for epithelial morphogenesis
(Bissell et al., 1982) and cancer (Nelson et al., 2008; Xu et al.,
2009). Accordingly, plasticity and reciprocity account for the
morphologic and functional inter- and intralesion heterogeneity
driven by complementary mechanisms, including genomic insta-
bility as well as epigenetic, signaling, and functional adaption to
cope with altering environmental conditions (Figure 6A). Such
‘‘fate-changing’’ events that trigger significant adaptation in
tumor cells occur in response tometabolic changes in themicro-
environment, including hypoxia and severe metabolic stress
(Bertout et al., 2008), as well as chronic growth factor stimulation
and inflammation (Allinen et al., 2004; Polyak et al., 2009)
(Figure 6B).
A critical common mediator of plasticity and reciprocity is the
change of cell position. Cell invasion provides access to different
physicalandmolecular structures, including the local tumorstroma
and secondary organs after metastatic colonization, and thus
refines signaling input (Figures 6B and 6C). Consequently, cancer
invasion and metastasis are both cause and consequence of
plasticity and reciprocity. Over time, the changes driving adaptive
reprogramming of tumor cells and the reactive tumor stroma thus
lead to a kinetic, ever-changing coevolution of the tumor with its
environment (Hanahan and Weinberg, 2011; Polyak et al., 2009).
Related tissue remodeling processes, such as morphogenesis
andwoundhealing, followwell-definedprogramswith rate-limiting
steps and end points (e.g., for limb or organ formation or closure of
a tissue defect). In contrast, cancer is more flexible in time, space,Cell 147, November 23, 2011 ª2011 Elsevier Inc. 1003
Figure 6. Reciprocity, Plasticity, and Evolution of Tumor Cell Inva-
sion and Metastasis
(A) Reciprocal crosstalk between tumor cells and the stroma (i.e., stromal cells
together with ECM and released factors) results in evolutionary plasticity of
both tumor cells and the tissue environment. ‘‘Reciprocity’’ results from the
bidirectional communication between stromal (S) and tumor (T) compart-
ments, which is transmitted by mediators (M) released by both compartments
in a reciprocal manner. Stromal alterations include cell-derived physico-
chemical changes of the microenvironment, such as deposited ECM
components, ECM degradation and remodeling, change of ECM stiffness and
porosity, and released cytokines and growth factors. Plasticity of the cell
phenotype and function consists of: changes in the activation, migration, and
differentiation state of the cell; metabolic switches; and epigenetic alterations
that may further prompt secondary genomic instability. Consequently, with
each cycle of interactive engagement with the stroma, the cell state diverges
from its origin, leading to progression of the tumor or the metastasis (indicated
as spiral).
(B) Branching and altered direction of reciprocal plasticity in the course of
cancer progression. Direction-changing dichotomy is reached by a change in
the position of the tumor cell, which results in a different tissue location and
change in environmental input (upper spirals); likewise, step-wise bifurcation
of reciprocal evolution may be induced by changes of the local tissue condi-
tions, including altered composition of infiltrate cells during inflammatory and
metabolic stress, insufficient perfusion resulting in hypoxia, and tissue repair
programs induced by spontaneous or therapy-induced (tumor) necrosis (lower
spirals).
(C) Second- and third-order reciprocity. Reciprocal plasticity can evolve during
metastatic progression to generate second- and third-order reciprocity. In the
course of metastasis, tissue-specific reciprocity and microenvironmental
1004 Cell 147, November 23, 2011 ª2011 Elsevier Inc.signaling programs, and genetics and thus represents a perpetu-
ating process without a clear end point, illustrated here as open-
ended spirals (Figure 6).
Concluding Remarks
Well-defined experimental conditions in vitro have allowed the
precise delineation of receptor-ligand interactions and their
basic involvement in invasive migration, but their complexity
and synergistic availability in vivo make it challenging to identify
the dominant and compensation mechanisms that maintain and
rescue metastatic dissemination (Friedl and Wolf, 2003; Madsen
and Sahai, 2010; Sanz-Moreno and Marshall, 2010). Although
the intracellular machinery that generates force via actomyosin
is well-defined, the range of molecular and physical adhesion
and transmission modes at the cell and tissue level support the
adaptation of cell migration. This adaptation is similar to and
likely intertwined with the compensation and plasticity of focal
adhesion and other signaling networks during cell invasion
(Zaidel-Bar et al., 2007). Consequently, because most pathways
of adhesion, proteases, and chemokine/growth factors exhibit
ample overlap and redundancy, the natural or therapeutically
induced loss of one mechanistic pathway may lead to a drift in
signaling and mechanotransducing effector networks. This
may trigger alternative mechanisms of invasion and dissemina-
tion instead of inhibiting function.
Recent studies identified two unexpected examples for alter-
native migration modes in 3D environments: the interstitial mi-
gration of leukocytes independently of integrin (Friedl and Wei-
gelin, 2008; La¨mmermann et al., 2008; La¨mmermann and Sixt,
2009) and the propulsive cell migration of normal and neoplastic
cells by blebs (Fackler and Grosse, 2008; Lorentzen et al., 2011;
Poincloux et al., 2011). The contribution of these types of cell
movement to metastatic cancer invasion in vivo awaits determi-
nation. In addition to active actomyosin-driven migration, other
mechanisms of cell transport include passive drift along tissue
structures and cell pushing by expansive growth. Both of these
alternative mechanisms still have not been formally integrated
into the spectrum of cell translocation principles.
The invaded tissue is often regarded as a homogeneous and
passive scaffold that the tumor cells modify in a unidirectional
manner, and indeed, this notion has been strengthened by
most 2D and 3D in vitro models (Friedl et al., 1997; Wolf et al.,
2009). The concept of plasticity and reciprocity of cancer inva-
sion, however, describes invasion as a reciprocal process gov-
erned by multiple sets of overlapping, redundant, and poten-
tially, ever-changing active and passive mechanisms of
molecular mechanotransduction. This adaptability renders cell
invasion and metastasis as a robust perpetuating process, the
targeting of which—if ever possible—will require understanding
the hierarchy of stringent control points. To this end, systems
biology and mathematical modeling approaches are required
to classify rate-limiting nodes andmodifiers ofmolecular mecha-
notransduction for each migration mode and tissue-context.inputs synergize to drive local plasticity of tumor cells and the tumor stroma,
resulting in the evolution of tumor subregions with diverse progression and
adaptation capabilities. As a consequence, reciprocity and plasticity may
impose parallel or divergent evolution of cell clones and populations.
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